MorphoSys AG MOR

Full chart Compare
Set alert

Price alert · MOR

All alert types
18.96 0.00 (+0.00%)

At closeAug 2, 2024, 4:00 PM EDT

18.38 Day range 19.15

52-week range unavailable

Revenue & Expenses

Revenue by
Other Income → Expenses: $59.93MExpenses → Selling, General & Admin: $92.54MExpenses → Research & Development: $283.61MExpenses → Other Operating Expenses: $54.63MIncome Tax Benefit → Expenses: $1.19MUnited States → Revenue: $211.48MGross Profit → Expenses: $179.92MRevenue → Gross Profit: $179.92MRevenue → Cost of Revenue: $58.35MEurope (Excluding Germany) → Revenue: $26.79MNet Loss → Expenses: $189.73MAsia → Revenue: $8.00KOther Income$59.93MIncome Tax Benefit$1.19MGross Profit$179.92MNet Loss$189.73MCost of Revenue$58.35MExpenses$430.78MSelling, General & Admin$92.54MResearch & Development$283.61MOther Operating Expenses$54.63MRevenue$238.28MUnited States$211.48MEurope (Excluding Germany)$26.79MAsia$8.00K

Latest period ending Dec 31, 2023 · select a line to chart its full history

MOR annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
238.28M278.27M179.61M327.70M71.76M
179.92M229.65M147.42M318.52M59.67M
-252.48M-220.71M-508.34M17.95M-108.10M
-189.73M-151.06M-514.46M97.89M-103.01M
-1.38-1.11-3.85—-0.815
MOR annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
158.50M402.35M123.25M109.79M44.31M
2.03B2.40B2.56B1.66B496.44M
1.98B2.24B2.31B1.04B101.74M
1.81B2.06B2.10B834.71M42.57M
49.05M157.41M244.88M621.32M394.70M
MOR annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-295.84M-366.71M-481.45M35.27M-81.07M
15.37M345.00M-831.01M-879.62M79.48M
43.00M311.42M1.32B907.19M353.24K
-349.47K-1.93M-3.81M-4.46M-3.08M
-243.85M279.10M13.45M66.23M-1.15M